FDA approves multiple sclerosis drug from Biogen and Alkermes
FDA approves multiple sclerosis drug from Biogen and Alkermes
Reuters: Health
Biogen Inc and partner Alkermes Plc said on Wednesday that the U.S. Food and Drug Administration approved their oral drug to treat multiple sclerosis.
Reuters: Health
Biogen Inc and partner Alkermes Plc said on Wednesday that the U.S. Food and Drug Administration approved their oral drug to treat multiple sclerosis.
Comments
Post a Comment